Munich, Dec 18, 2017
Veit Hornung investigates the mechanisms that enable the body’s innate immune system to distinguish between structures that are specific to invasive pathogens and molecules normally present in the infected cells. His research work contributes in particular to the development of therapeutic agents for the treatment of autoimmune diseases – and his name now appears among the winners of the Leibniz Prize 2018 announced by the Deutsche Forschungsgemeinschaft today. Hornung receives the Prize together with Professor Eicke Latz of Bonn University, whose work likewise focuses on the innate immune system.
Veit Hornung holds the Chair of Immunobiochemistry at LMU’s Gene Center investigates the mechansims that enable the how the innate immune system. Born in 1976, Hornung studied Medicine at LMU, and led a Junior Research Group in the Department of Clinical Pharmacology at the LMU Medical Center. Following a period as a Post-Doctoral Fellow at the University of Massachusetts Medical School in Worcester, he was appointed Professor of Clinical Biochemistry at Bonn University Hospital in 2008, and later served as Director oft he Institute of Molecular Medicine there, before taking up his present position at LMU in 2015.
The Leibniz Prize, worth up to 2.5 million euros, is regarded as the most important award for research excellence in Germany. The prize money can be used to support the awardee’s research for up to 7 years.